TRAVERE THERAPEUTICS INC
TVTX · NASDAQ
更新於 2026-10-14 11:32:33
$51.80-0.42%
- 今日最高
- $52.81
- 今日最低
- $51.38
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
...
K線圖趨勢，實際資料以交易頁為準
關鍵數據
- 昨天開盤價
- $51.74
- 昨天收盤價
- $52.02
- 成交量
- 1.42M
- 市值
- $4.9B
- 市盈率（P/E）
- --
- 每股收益（EPS）
- $-0.49
昨天價格區間
$51.74$53.35
52週價格區間
$22.59$68.73
公司概況
- 板塊
- 醫療保健
- 行業
- 生物科技
- 子行業
- 生物科技
- 總部
- 3611 VALLEY CENTRE DRIVE, SAN DIEGO, CA, UNITED STATES, 92130
- 國家
- 美國
- 上市日期
- 2003-07-23
- 財年截止
- 十二月
- 流通股數
- 92.99M
- CIK
- 0001438533
- 官方網址
- travere.com
Travere Therapeutics, Inc. 是一間生物製藥公司，專注於罕見疾病治療療法的識別、開發及商業化。公司總部位於加利福尼亞州聖地亞哥。
財務指標
營業收入
2026-06-30
$169.58M
2026-03-31
$127.19M
2025-12-31
$129.68M
2025-09-30
$164.85M
營業支出
2026-06-30
$163.45M
2026-03-31
$137.34M
2025-12-31
$159.56M
2025-09-30
$138.34M
淨利潤
2026-06-30
-$34.79M
2026-03-31
-$37.1M
2025-12-31
$2.72M
2025-09-30
$25.7M
淨利潤率
2026-06-30
-20.51%
2026-03-31
-29.16%
2025-12-31
2.1%
2025-09-30
15.59%
每股收益
2026-06-30
$-0.37
2026-03-31
$0.05
2025-12-31
$0.37
2025-09-30
$0.59
息稅折舊攤銷前利潤
2026-06-30
-$28.63M
2026-03-31
-$9.21M
2025-12-31
-$632K
2025-09-30
$44.25M
有效稅率
2026-06-30
0.58%
2026-03-31
0.32%
2025-12-31
-4.37%
2025-09-30
0.03%
| 項目 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| 營業收入 | $169.58M | $127.19M | $129.68M | $164.85M |
| 營業支出 | $163.45M | $137.34M | $159.56M | $138.34M |
| 淨利潤 | -$34.79M | -$37.1M | $2.72M | $25.7M |
| 淨利潤率 | -20.51% | -29.16% | 2.1% | 15.59% |
| 每股收益 | $-0.37 | $0.05 | $0.37 | $0.59 |
| 息稅折舊攤銷前利潤 | -$28.63M | -$9.21M | -$632K | $44.25M |
| 有效稅率 | 0.58% | 0.32% | -4.37% | 0.03% |
常見問題
風險提示
股價可能大幅波動，短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考，不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。